UTI (NYSE) Form 144: Broker named and multiple vested restricted-share lots listed

Rhea-AI Filing Summary

UTI submitted a Form 144 notice describing proposed sales of Common Stock tied to multiple restricted stock vesting lots. The filing lists vesting dates and quantities such as 1,625 shares (09/05/2015), 2,772 shares (01/07/2022), and 3,356 shares (12/08/2022).

The filing names Fidelity Brokerage Services LLC as the broker-dealer and includes an entry dated 03/02/2026 with an NYSE designation.

Insights

Corporate Governance Analyst

Form 144 lists scheduled restricted-share vesting lots and a broker-dealer for proposed sales.

The filing itemizes multiple restricted-stock vesting entries by date and share count, for example 1,625 shares on 09/05/2015 and 3,356 shares on 12/08/2022. It names Fidelity Brokerage Services LLC as the broker-dealer and shows a filing-related date of 03/02/2026.

These notices indicate an affiliate's intent to sell under applicable resale rules; actual sales, timing, and proceeds are not shown in the excerpt and will depend on subsequent transactions and compliance with resale conditions.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 05:07 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	22671	841197.29	55020506	03/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/05/2015	Restricted Stock Vesting	Issuer			1625	09/05/2015	Compensation
Common	09/20/2015	Restricted Stock Vesting	Issuer			1299	09/20/2015	Compensation
Common	09/05/2016	Restricted Stock Vesting	Issuer			1625	09/05/2016	Compensation
Common	09/20/2016	Restricted Stock Vesting	Issuer			1299	09/20/2016	Compensation
Common	09/05/2017	Restricted Stock Vesting	Issuer			1625	09/05/2017	Compensation
Common	09/20/2017	Restricted Stock Vesting	Issuer			633	09/20/2017	Compensation
Common	01/07/2021	Restricted Stock Vesting	Issuer			2545	01/07/2021	Compensation
Common	01/07/2022	Restricted Stock Vesting	Issuer			2772	01/07/2022	Compensation
Common	12/08/2022	Restricted Stock Vesting	Issuer			3356	12/08/2022	Compensation
Common	12/10/2022	Restricted Stock Vesting	Issuer			3319	12/10/2022	Compensation
Common	01/07/2023	Restricted Stock Vesting	Issuer			2573	01/07/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does UTI's Form 144 disclose about the securities?

The filing lists proposed sales of Common Stock from restricted-stock vesting lots. It details specific vesting dates and share counts such as 1,625 shares (09/05/2015) and 3,356 shares (12/08/2022) tied to compensation.

Who is the broker‑dealer named in the UTI Form 144?

The filing names Fidelity Brokerage Services LLC as the broker‑dealer. The document also includes an entry dated 03/02/2026 and references the NYSE in the header.

Do the listed vesting entries mean shares were sold?

No. The Form 144 excerpt records proposed sales tied to vesting lots and provides share counts and dates. It does not report completed sales, transaction prices, or proceeds from any sale.

How can investors find details on any actual sales for UTI?

Look for subsequent insider reports (Forms 3/4/5) or broker-dealer trade records. The Form 144 shows intent and vesting lots but not completed transaction details or proceeds.